IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 60 filers reported holding IRADIMED CORP in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $111,192 | -7.1% | 2,506 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $119,637 | +22.8% | 2,506 | +1.2% | 0.00% | +50.0% |
Q1 2023 | $97,431 | +39.8% | 2,476 | +0.5% | 0.00% | 0.0% |
Q4 2022 | $69,707 | -5.8% | 2,464 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $74,000 | -11.9% | 2,464 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $84,000 | -23.6% | 2,464 | 0.0% | 0.00% | -33.3% |
Q1 2022 | $110,000 | -46.6% | 2,464 | -44.7% | 0.00% | -25.0% |
Q4 2021 | $206,000 | +38.3% | 4,456 | +0.4% | 0.00% | 0.0% |
Q3 2021 | $149,000 | +14.6% | 4,440 | +0.2% | 0.00% | +33.3% |
Q2 2021 | $130,000 | +14.0% | 4,433 | +0.6% | 0.00% | 0.0% |
Q1 2021 | $114,000 | +15.2% | 4,405 | +1.0% | 0.00% | 0.0% |
Q4 2020 | $99,000 | +6.5% | 4,360 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $93,000 | -7.9% | 4,360 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $101,000 | +8.6% | 4,360 | 0.0% | 0.00% | -25.0% |
Q1 2020 | $93,000 | -8.8% | 4,360 | 0.0% | 0.00% | +33.3% |
Q4 2019 | $102,000 | +10.9% | 4,360 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $92,000 | +3.4% | 4,360 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $89,000 | – | 4,360 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Nine Ten Capital Management LLC | 781,766 | $22,116,000 | 3.84% |
Soleus Capital Management, L.P. | 745,004 | $21,076,163 | 3.02% |
RK Capital | 366,000 | $10,354,140 | 2.45% |
Capital Impact Advisors, LLC | 20,370 | $576,267 | 0.56% |
Ranger Investment Management | 198,635 | $5,619,384 | 0.42% |
Bares Capital Management | 271,300 | $7,675,077 | 0.29% |
Hillsdale Investment Management Inc. | 108,500 | $3,069,465 | 0.26% |
CORNERCAP INVESTMENT COUNSEL INC | 36,790 | $1,040,789 | 0.18% |
RICE HALL JAMES & ASSOCIATES, LLC | 73,238 | $2,071,903 | 0.12% |
CIM, LLC | 9,014 | $318,149 | 0.06% |